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Introduction
Non-communicable diseases (NCDs) are estimated to be
the leading causes of morbidity and mortality in devel-
oping countries, especially Africa [1-3]. About 20 per-
cent of the deaths from NCDs in Africans over the age
of 45 years of age is from cancer [4]. Known as Africa’s
silent killer, cancer is now a major public health pro-
blem in Africa, with the five most frequent cancers
being Breast, Cervix, Liver, Prostate and Non-Hodgkin
Lymphoma [1]. However, cancer continues to be under-
estimated and ignored in Africa. The little attention
being given to cancer has led to unnecessary deaths and
suffering from cancer, indicating a need for cancer advo-
cacy as one of several strategies for creating awareness
of cancer in local and national communities and the
need to commit resources aimed at achieving cancer
control objectives. Unfortunately, cancer advocacy is
currently limited and weak in Africa, thereby making
cancer issues of low priority in African countries.
A long-term goal of the organizers of the conference is
to make cancer a top priority in Africa. In pursuit of this
goal, the objective of this workshop was to train cancer
advocates who will be empowered to engage their com-
munities, develop, and implement cancer health and sur-
vivorship programs. The workshop was designed to
provide participants with the skills to: (1) mobilize the
resources within African countries for health promotion,
prevention, and survivorship strategies; (2) partner with
key stakeholders to accomplish targeted objectives; (3)
raise funds to support advocacy activities; and (4) develop
and successfully organize community-centered programs.
The specific objectives for the participants included to:
1. Provide opportunities for mutual learning, knowledge
transfer, and collaborations among cancer advocates.
Participants were provided with learning opportunities to:
a. Assess and track the cancer health needs of their
communities;
b. Conduct a SWOT analysis to develop effective stra-
tegies, including the development of a local community
action plan;
c. Initiate and develop partnerships with other stake-
holders to address the needs of their communities;
d. Organize and implement programs to: (i) raise pub-
lic awareness about cancer, (ii) provide support to those
living with cancer, (iii) help advance cancer research
and training, (iv) improve the quality of cancer care, and
(v) address legislative and regulatory issues that affect
cancer care and research in Africa; and
e. Utilize evaluation tools to determine, document,
and improve the program outcomes of programs imple-
mented in their communities.
2. Facilitate networking among individuals involved in
cancer control, education and research in Africa.
3. Facilitate the development of a global community of
practice to address common challenges in cancer advo-
cacy in Africa.
4. Contribute to a global impact against cancer
through advocacy.
The International Workshop on Cancer Advocacy for
African Countries (CAAC) was organized by the Univer-
sity of Florida, the Prostate Net® and the African Organi-
sation for Research and Training in Cancer (AORTIC) in
partnership with several other organizations including
the National Cancer Institute and World Wide Prostate
Cancer Coalition. The conference was held in Cairo, Egypt
on November 29, 2011. A total of 73 delegates participated
in the conference including delegates from Africa, the Car-
ibbean, the United Kingdom, Italy, Germany, Canada, and
America. Thirty delegates representing thirteen African
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countries were selected as recipients of scholarship
funding.
The Opening Session began with opening remarks
and a welcoming of the workshop delegates by Professor
Folakemi Odedina (Conference Chair) and a program
overview provided by Mr. Virgil Simons (Conference
Co-Chair). The opening presentation titled “Setting the
Stage for Cancer Advocacy in Africa: What and
Why?” was given by Professor Odedina (USA) and
Mr. Simons (USA). Professor Odedina offered insights
based on her experiences in Nigeria and elsewhere in
Africa in developing cancer advocacy initiatives, including
the establishment of a National Cancer Awareness month
in Nigeria and other advocacy efforts such as organizing
Cancer Control meetings at the local, regional, national
and international levels and conducting media programs
to educate the public on cancer and raise awareness. Their
presentation also covered the principles of advocacy and
types of advocacy appropriate for cancer control.
This presentation set the stage for small group Round-
table Discussions on best practices for cancer advocacy.
This session, presided by Professor Ogunbiyi (Nigeria),
involved six roundtables: support advocacy presided by
Kandusi (Tanzania), community outreach advocacy pre-
sided by Bekele (Ethiopia), education advocacy presided by
Kamara (Sierra Leone), political advocacy presided by Dar-
amola (Nigeria), research advocacy presided by Mapara
(Zimbabwe), and fundraising advocacy presided by Stevn
(South Africa). Following the roundtable discussions, the
presiders for each roundtable reported a set of action
items resulting from the discussions, which is summarized
as part of the proceedings.
Professor Odedina (USA) described the importance of
conducting locally-based needs assessments in the area of
cancer control and the process used for performing these
assessments in her presentation titled “Understanding
Your Community and Assessing your Community
Health Assets and Needs.” Her presentation addressed
the actions steps necessary for conducting a needs assess-
ment including assembling the community team, develop-
ing a team strategy, reviewing community sectors,
gathering, entering, reviewing data, and building a com-
munity action plan. She concluded her presentation by
reminding the delegates that if the problems are in the
community, the solutions are also in the community.
The workshop also examined how cancer advocates
may engage politicians and researchers. The keynote pre-
sentation titled “Partnering with Elected Officials to
Advocate Cancer-Related Policies” was given by former
Senator Anthony Hill Sr. (Minority Whip, Florida, USA).
Senator Hill’s presentation offered insights to the political
process in the USA and how cancer advocates can best
position their messages for action by politicians. Scott
Williams (USA), representing the Men’s Health Network,
presided over a Prostate Cancer Roundtable on the
topic of Gaining Political Advantage. Mr. Williams dis-
cussed the role of non-profit organizations in forming
health prevention messages and developing initiatives
especially in the area of cancer control. This presentation
was followed by Professor Tim Rebbeck (USA) and Virgil
Simons (USA) discussing the importance for cancer
advocates and the research community to develop strate-
gic partnerships in a presentation titled “Finding the
Lethal Phenotype: Research Partnership Needs.” Pro-
fessor Rebbeck discussed what is needed to develop
research capacity in Africa, emphasizing the need for
dedicated influential local principal investigators (PIs), an
environment that fosters PIs, research goals which are
achievable with a realistic timeframe, and strong mentors
with bi-directional visits between mentors and local PIs.
In the next session, Professor Renee Reams (USA)
described methods she has used to engage the media to
promote health prevention initiatives in a presentation
titled “Engaging the Media & Promoting Your Pro-
gram.” The next discussion was led by Professor Fola-
kemi Odedina and Mr. Virgil Simons on the formation
of the African Cancer Advocacy Consortium (ACAC) at
this workshop. They noted that the mission is making
cancer a top priority in Africa and described the organi-
zation of ACAC, noting six types of advocacy groups
comprising ACAC: (1) political advocacy, (2) education
advocacy, (3) research advocacy, (4) fundraising advo-
cacy, (5) support advocacy, and (6) community outreach
advocacy. An interim ACAC Advisory Board was identi-
fied and a chair and co-chair for each advocacy group
was selected.
The workshop closed with the program assessment
and feedback conducted by Professor Richard Segal
(USA). Participants provided their evaluations on the
overall program, the workshop sessions, and the speak-
ers. In addition, feedback was obtained on suggested
improvements for the 2013 workshop. Before closing
the workshop, delegates were invited to join one or
more of the advocacy groups.
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